Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
ALZHEIMER'S
Given that 26 million people worldwide have Alzheimer's disease and 106 million could be afflicted by 2050, any treatment that alters the course of the disease will become a multi-billion-dollar drug. Major pharmaceutical companies and biotech startups are racing to develop the first drugs to delay or reverse Alzheimer’s. Medical device makers are also developing screening tests to more accurately diagnose Alzheimer’s, and health care providers are trying to find ways to better manage patients.
Alzheimer's is part of Business Exchange, suggested by
Cathy Arnst.
This topic contains
1,244 news
and
1,139 blog
items.
Read updated news, blogs, and resources about Alzheimer's. Find user-submitted articles and reactions on Alzheimer's from
like-minded professionals.
Most Active
The most active stories in this topic based on user activity.
Stem cell-based therapies offer potential new ways to treat diseases for which there is no current cure, including...
The drug (J147) may be the first capable of halting mental decline associated with Alzheimer's disease.
Many Alzheimer's researchers are targeting other potential causes [of Alzheimer's], like tau protein tangles and...
I am witnessing the dawn of a new age of Alzheimers disease, an age that will be marked by the end of Alzheimers...
Sixty percent of persons living with Alzheimer's wander. The GPS tracking shoe could be the answer to this problem.
Many people with dementia are living with "excess disability."
In this video Deepak Chopra talks to Dr. Rudy Tanzi about his groundbreaking research project, the Alzheimer's Genome...
Donepezil is marketed under the brand name Aricept by its developer Eisai (TSE) and partner Pfizer (PFE).
...and safe recovery of individuals with Alzheimer’s disease and other...
"It appears that there may be a very high rate of cognitive impairment in these retired football players, compared...
Dotty performs live, and talks with Harvey the Parrot Dotty is 95 years old and lives with Alzheimer's.
The changing tide of Alzheimer's diagnosis presents new challenges to the public, physicians and lawmakers: if you...
"For many older adults, cognitive impairment contributes to loss of independence, decreased quality of life and...
WASHINGTON, DC—Alzheimer's sufferers from across the nation marched on random buildings throughout Washington, D.C.
Johnson & Johnson took over development of bapineuzumab, when it bought Elan's Alzheimer’s program last year.
An existing anti-seizure drug improves memory and brain function in adults with a form of cognitive impairment that...
Watch this video and learn how a non-responsive dementia patient in hospice was awakened when caregivers focused on her...
The person may be at risk for isolation and depression, anxiety, resistance to care, and similar behavior disturbances.
In a nutshell, dementia is a symptom, and AD is the cause of the symptom. When someone is told they have dementia, it...
The youngest sufferer of Alzheimer's, Rebecca Doig from Sydney, became mum last week. she does not, however, remember...
Initial reports of Phase II study results of bapineuzumab, a humanized monoclonal antibody to beta amyloid being tested...
Medivation (MDVN) is expected to release the results of its Phase 3 clinical trial of Dimebon in the not to distant...
Henry McCance is considered to be one of the world's best venture capitalist. Rudy Tanzi is a world class geneticist...
"Animal Models of Alzheimer's Disease: Therapeutic Implications." Journal of Alzheimer's disease [1387-2877]...
Top Sources: Alzheimer's
- alzheimersreadingroom.com
- ShoutWire.com
- alzheimersteam.com
- I-Newswire.com - Free Press Release Distribution
- PennTags Feed for /
- DaniWeb IT Discussion Community
- Reuters
- US News
- Medindia Health News
- New York Times
account